Cancer and thrombosis: new insights to an old problem

Area of Science:

• Oncology
• Hematology
• Thrombosis Research

Background:

• Venous thromboembolism (VTE) is a frequent and serious complication in cancer patients.
• Malignancy triggers a pro-thrombotic state through venous stasis, endothelial injury, and imbalanced coagulation factors.
• Historical understanding of cancer-related hypercoagulability, including Virchow's triad, provides a foundation for current research.

Purpose of the Study:

• To elucidate the complex pathophysiology of VTE in cancer patients.
• To identify patient-specific, treatment-related, and tumor-specific factors contributing to thrombosis.
• To underscore the importance of understanding these factors for effective thromboprophylaxis.

Main Methods:

• Review of existing literature on cancer and VTE pathophysiology.
• Analysis of factors contributing to hypercoagulability in malignancy.
• Synthesis of knowledge regarding venous stasis, endothelial injury, and coagulation factor imbalance.

Main Results:

• Cancer inherently induces a hypercoagulable state.
• Multiple factors (patient, treatment, tumor) exacerbate thrombosis risk.
• A comprehensive understanding of these factors is crucial for clinical decision-making.

Conclusions:

• Cancer-associated thrombosis is multifactorial, involving intrinsic malignancy effects and external factors.
• Identifying patients at high risk for VTE is essential for implementing appropriate preventative strategies.
• Further research into thromboprophylaxis in cancer patients is warranted.